AI-assisted, human-published
10/01/2026 /Funding Events
R1 Therapeutics Raises Series A to $80.5M with Samsara BioCapital
R1 Therapeutics expands its Series A to $80.5M with Samsara BioCapital, reinforcing investor conviction in kidney disease programs after a prior oversubscribed round.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com